Case Report Open Access
Copyright ©The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. May 14, 2016; 22(18): 4604-4609
Published online May 14, 2016. doi: 10.3748/wjg.v22.i18.4604
Pseudo-Meigs’ syndrome secondary to metachronous ovarian metastases from transverse colon cancer
Kennoki Kyo, Atsushi Maema, Motoaki Shirakawa, Toshio Nakamura, Hidetaro Yokoyama, Department of Surgery, Fujieda Municipal General Hospital, Fujieda, Shizuoka 426-8677, Japan
Kenji Koda, Department of Pathology, Fujieda Municipal General Hospital, Fujieda, Shizuoka 426-8677, Japan
Author contributions: Kyo K served as an attending doctor for the patient, performed the surgery, and wrote the manuscript; Maema A, Shirakawa M, Nakamura T, Koda K and Yokoyama H were involved in editing the manuscript; and Koda K performed the pathological examination.
Supported by Fujieda Municipal General Hospital, Surugadai, Fujieda, Shizuoka, Japan.
Institutional review board statement: This study was reviewed and approved by the Institutional Review Board of Fujieda Municipal General Hospital.
Informed consent statement: Informed consent was waived because the patient was deceased.
Conflict-of-interest statement: The authors declare no conflicts of interest for this article.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Kennoki Kyo, MD, PhD, Department of Surgery, Fujieda Municipal General Hospital, 4-1-11 Surugadai, Fujieda, Shizuoka 426-8677, Japan. kkyo@vega.ocn.ne.jp
Telephone: +81-54-6461111 Fax: +81-54-6461122
Received: January 19, 2016
Peer-review started: January 21, 2016
First decision: February 18, 2016
Revised: March 2, 2016
Accepted: March 14, 2016
Article in press: March 14, 2016
Published online: May 14, 2016

Abstract

Pseudo-Meigs’ syndrome associated with colorectal cancer is extremely rare. We report here a case of pseudo-Meigs’ syndrome secondary to metachronous ovarian metastases from colon cancer. A 65-year-old female with a history of surgery for transverse colon cancer and peritoneal dissemination suffered from metachronous ovarian metastases during treatment with systemic chemotherapy. At first, neither ascites nor pleural effusion was observed, but she later complained of progressive abdominal distention and dyspnea caused by rapidly increasing ascites and pleural effusion and rapidly enlarging ovarian metastases. Abdominocenteses were repeated, and cytological examinations of the fluids were all negative for malignant cells. We suspected pseudo-Meigs’ syndrome, and bilateral oophorectomies were performed after thorough informed consent. The patient’s postoperative condition improved rapidly after surgery. We conclude that pseudo-Meigs’ syndrome should be included in the differential diagnosis of massive or rapidly increasing ascites and pleural effusion associated with large or rapidly enlarging ovarian tumors.

Key Words: Pseudo-Meigs’ syndrome, Colon cancer, Ascites, Pleural effusion, Ovarian metastasis

Core tip: Pseudo-Meigs’ syndrome associated with colorectal cancer is extremely rare. Here, we report a case of this syndrome secondary to metachronous ovarian metastases from transverse colon cancer. This patient complained of progressive abdominal distention and dyspnea preoperatively, but her postoperative condition improved rapidly after bilateral oophorectomies. We conclude that pseudo-Meigs’ syndrome should be included in the differential diagnosis of massive or rapidly increasing ascites and pleural effusion associated with large or rapidly enlarging ovarian tumors.



INTRODUCTION

Meigs’ syndrome is defined by the presence of a benign ovarian tumor with ascites and pleural effusion that resolve after removal of the tumor[1]. The ovarian tumors in Meigs’ syndrome are fibromas or fibroma-like tumors, and other benign or malignant pelvic tumors associated with ascites and pleural effusion are described as pseudo-Meigs’ syndrome[2]. Pseudo-Meigs’ syndrome associated with colorectal cancer is extremely rare, and the etiology of ascites and pleural effusion in this syndrome remains unknown. We describe here a case of pseudo-Meigs’ syndrome secondary to metachronous ovarian metastases from transverse colon cancer and discuss the etiology of the ascites and pleural effusion in this syndrome.

CASE REPORT

A 65-year-old female with a history of surgery for ileus due to transverse colon cancer was admitted to our department for the induction of oxaliplatin-based chemotherapy. During the previous surgery, we had found numerous nodules of peritoneal dissemination, each 1 mm in size under the right diaphragm and in the pelvis, as well as sparsely distributed nodules of similar size on the mesentery of the small intestine. Furthermore, a disseminated nodule 5 mm in size had been observed in the greater omentum. We had performed right hemicolectomy with ileocolic anastomosis and omentectomy. Pathologically, moderately differentiated adenocarcinoma had been observed in the colonic tumor and in the resected nodule in the omentum, and no lymph node metastasis had been observed. After 1 year and 3 mo of treatment with irinotecan-based chemotherapy, computed tomography (CT) examination performed 22 d before admission revealed bilateral enlarged ovaries with solid and cystic components, suggesting bilateral ovarian metastases (Figure 1A). Although neither ascites nor pleural effusion had been observed in the CT examination, the patient had already gained more than 4 kg, and a moderate amount of ascites had been identified by an abdominal ultrasound examination performed 9 d before admission. Four days after admission, she complained of abdominal distention and bilateral edema of the legs, and an abdominal ultrasound examination completed on the same day identified massive ascites and a small amount of bilateral pleural effusion. She soon became unable to eat because of abdominal distention. She also complained of progressive dyspnea, and at worst, her oxygen saturation was 88% in room air. CT examination performed 26 d after admission showed a large amount of ascites and pleural effusion with left-side predominance (Figure 1B and C). Bilateral ovarian tumors showed a rapid increase in size, and the left and right ovaries measured 97 mm × 66 mm and 80 mm × 29 mm, respectively (Figure 1B and C). Abdominocenteses were performed three times, and cytological examinations of the fluids were all negative for malignant cells. Despite the diffuse peritoneal dissemination observed during the previous surgery, we suspected pseudo-Meigs’ syndrome caused by metastatic ovarian tumors and recommended the patient for surgery. Laboratory tests prior to surgery showed carcinoembryonic antigen (CEA) levels at 2.9 ng/mL (normal, < 5 ng/mL), carbohydrate antigen (CA) 19-9 levels at 51.4 U/mL (normal, < 37 U/mL), and CA 125 levels at 1150.0 U/mL (normal, < 35 U/mL). After thorough informed consent, a laparotomy was performed by lower abdominal incision, and more than 3.6 L of serous fluid was removed. Bilateral oophorectomies were performed, and a drainage tube was inserted into the Douglas’ pouch. Although we could not inspect the right subphrenic region from the incision, we did not find any of the peritoneal nodules formerly observed on the mesentery of the small intestine and in the pelvis. The resected tumors from the left and right ovaries measured 90 mm × 55 mm and 30 mm × 30 mm, respectively (Figure 2A and B). Pathological examination revealed moderately differentiated adenocarcinoma of the ovaries that had negative immunohistochemical staining for cytokeratin (CK) 7 but positive staining for CK18, CK19 and CK20, leading to the diagnosis of bilateral ovarian metastases from colon cancer (Figure 2C and D). The patient’s postoperative condition improved rapidly after surgery. The amount of fluid drained through the abdominal tube during postoperative day 1 was 150 mL, and the tube was removed 2 d after the surgery. Although the feeling of abdominal distention diminished soon after the surgery, both body weight and abdominal girth did not change for 3 d after the surgery but rapidly decreased thereafter (Figure 3). After hospital discharge, she was treated with chemotherapy, and a pulmonary metastasis was resected 1 year after the oophorectomies. Recurrence of peritoneal dissemination was suspected by CT examination 2 years and 4 mo after the oophorectomies, and jejuno-jejunal bypass was performed for jejunal obstruction 5 years and 2 mo after the oophorectomies. She died of cancer 6 years and 11 mo after the first operation and 5 years and 6 mo after the oophorectomies.

Figure 1
Figure 1 Computed tomography of the abdomen. A: The examination performed 22 d before admission showed bilateral enlarged ovaries with solid and cystic components (arrows). Ascites was not visible; B and C: The examination performed 26 d after admission revealed massive ascites and pleural effusion and rapid enlargement of ovarian tumors (arrows).
Figure 2
Figure 2 Pathological analysis. A, B: Cross-sectional views of the left and right ovarian tumors, respectively. The left ovarian tumor measured 90 mm × 55 mm, and the right ovarian tumor measured 30 mm × 30 mm. Both tumors contained solid and cystic components; C, D: Microscopic views of the left and right ovarian tumors, respectively, showing moderately differentiated adenocarcinoma.
Figure 3
Figure 3 Line graphs showing changes in body weight and abdominal girth. Note that the body weight increased more than 4 kg before the emergence of ascites and that both the body weight and abdominal girth did not change for 3 d after surgery but thereafter decreased rapidly. CT: Computed tomography; US: Ultrasound.
DISCUSSION

In 1937, Meigs and Cass[1] described 7 cases of ovarian fibromas associated with ascites and pleural effusion, and these manifestations were subsequently termed Meigs’ syndrome[3]. Pseudo-Meigs’ syndrome associated with colorectal cancers is extremely rare, and only 11 cases, including the present case, have been reported in the English literature (Table 1)[4-13]. Eight out of these 11 cases were reported in Japan, and most of the patients were under 60 years of age, which is younger than the mean age for the development of colorectal cancers in the general population. There seems to be no preponderance in the locations of the primary lesions, and the associated ovarian metastases were metachronous in only 3 cases, including this case. Because of the metachronous development of this syndrome, we could observe the patient in detail from its early phase.

Table 1 Characteristics of reported cases of pseudo-Meigs’ syndrome associated with colorectal cancers.
Ref.YearAge (yr)Primary siteOnset of syndrome
Ryan[4]197235Transverse colonSynchronous
Matsuzaki et al[5]199239RectumSynchronous
Nagakura et al[6]200053Sigmoid colonSynchronous
Ohsawa et al[7]200341Sigmoid colonSynchronous
Feldman et al[8]200449CecumMetachronous
Rubinstein et al[9]200961CecumSynchronous
Hosogi et al[10]200944Ascending colonSynchronous
Okuchi et al[11]201042RectumMetachronous
Maeda et al[12]201158Sigmoid colonSynchronous
Saito et al[13]201244Sigmoid colonSynchronous
Present case201665Ascending colonMetachronous

The etiology of ascites in this syndrome is unclear, although several theories have been proposed. First, Meigs suggested that irritation of the peritoneal surface by a hard solid ovarian tumor could stimulate the production of peritoneal fluid[14]. A second theory is that ascites develops due to pressure on the superficial lymphatics of the tumor[3]. A third theory is that stromal edema and transudation may occur as a result of a discrepancy between the arterial supply to a large tumor and the venous and lymphatic drainage of the same mass[15]. A fourth theory suggests that excessive production of fluid by the peritoneum leads to ascites in this syndrome[16]. The last but probably the most plausible theory is that increased capillary permeability and the resultant third-space fluid shift occur due to increased levels of inflammatory cytokines and vascular endothelial growth factor (VEGF)[17]. Abramov et al[17,18] reported high levels of interleukin (IL)-1beta, IL-6, IL-8, VEGF and fibroblast growth factor in serum, ascites and pleural effusion and a decline in serum levels of these inflammatory cytokines and vasoactive factors after removal of the ovarian tumor and suggested that the release of these factors from the tumor should be involved in the clinical manifestations of this syndrome by inducing capillary leakage and third-space fluid accumulation. The clinical manifestations of Meigs’ syndrome show great similarity with a severe form of ovarian hyperstimulation syndrome (OHSS) that is associated with injection of human chorionic gonadotropin (hCG) and is also characterized by massive cystic enlargement of the ovaries, ascites and pleural effusion[19]. In severe OHSS, ascites and pleural effusion develop due to increased capillary permeability and resultant third-space fluid shift, and VEGF produced from ovarian follicles under the prolonged effects of hCG is thought to play a key role[19,20]. The site of VEGF production in patients with pseudo-Meigs’ syndrome is currently unclear. Okuchi et al[11] reported that immunohistochemical staining examinations showed increased VEGF expression in oviduct epithelial cells of both metastatic and non-metastatic sides rather than in tumor cells. Given that increased capillary permeability and resultant third-space fluid shift form part of the etiology of ascites in this syndrome, this may explain why the body weight of the present patient had increased well before the emergence of ascites and why both body weight and abdominal girth did not change for 3 d after removal of the ovarian tumors and insertion of a drainage tube.

The etiology of pleural effusion also remains unclear, but the prevailing theory is that the transfer of ascites occurs through transdiaphragmatic lymphatics, which was demonstrated by the flow of intraperitoneally injected India ink from the peritoneum to the pleural cavity[21]. Terada et al[22] also demonstrated that labeled albumin injected into the peritoneum was detected in the right pleura in maximum concentration within 3 h. However, considering the similarity of this syndrome to severe OHSS, increased capillary permeability may also be involved in the etiology of pleural effusion.

While it may be difficult, it is very important to distinguish the clinical manifestations of pseudo-Meigs’ syndrome with those of disseminated malignant disease because in the case of this syndrome, removal of ovarian tumors will markedly improve not only the quality of life but also the prognosis of the patient. Thus, pseudo-Meigs’ syndrome should be included in the differential diagnosis of massive or rapidly increasing ascites and pleural effusion associated with large or rapidly enlarging ovarian tumors.

COMMENTS
Case characteristics

The patient was a 65-year-old female who had surgery for ileus caused by transverse colon cancer.

Clinical diagnosis

Pseudo-Meigs’ syndrome.

Differential diagnosis

Peritoneal carcinomatosis.

Laboratory diagnosis

Laboratory tests before oophorectomies showed carcinoembryonic antigen (CEA) levels at 2.9 ng/mL (normal, < 5 ng/mL), carbohydrate antigen (CA) 19-9 levels at 51.4 U/mL (normal, < 37 U/mL), and CA 125 levels at 1150.0 U/mL (normal, < 35 U/mL).

Imaging diagnosis

Bilateral ovarian metastases with massive ascites and pleural effusion.

Pathological diagnosis

Moderately differentiated adenocarcinoma in the ovaries, compatible with metastases from transverse colon cancer.

Treatment

Bilateral oophorectomies.

Related reports

Pseudo-Meigs’ syndrome associated with colorectal cancer is extremely rare, and the etiology of ascites and pleural effusion in this syndrome remains unknown.

Term explanation

Meigs’ syndrome is defined by the presence of a benign ovarian tumor with ascites and pleural effusion that resolve after removal of the tumor. The ovarian tumors in Meigs’ syndrome are fibromas or fibroma-like tumors, and other benign or malignant pelvic tumors associated with ascites and pleural effusion are described as pseudo-Meigs’ syndrome.

Experiences and lessons

This case report may provide supporting evidence for the etiology of ascites and pleural effusion in pseudo-Meigs’ syndrome; our observations that the body weight of the patient had increased well before the emergence of ascites and that both the body weight and abdominal girth did not change for 3 d after removal of the ovarian tumors support the idea that increased capillary permeability and the resultant third-space fluid shift explain the etiology of ascites and pleural effusion in this syndrome.

Peer-review

The authors conclude that pseudo-Meigs’ syndrome should be included in the differential diagnosis of massive or rapidly increasing ascites and pleural effusion associated with large or rapidly enlarging ovarian tumors.

Footnotes

P- Reviewer: Chow CFK, Rodrigo L S- Editor: Ma YJ L- Editor: A E- Editor: Ma S

References
1.  Meigs JV, Cass JW. Fibroma of the ovary with ascites and hydrothorax: a report of seven cases. Am J Obstet Gynecol. 1937;33:249-266.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 208]  [Cited by in F6Publishing: 212]  [Article Influence: 2.4]  [Reference Citation Analysis (0)]
2.  Meigs JV. Pelvic tumors other than fibromas of the ovary with ascites and hydrothorax. Obstet Gynecol. 1954;3:471-486.  [PubMed]  [DOI]  [Cited in This Article: ]
3.  Rhoads JE, Terrell AW. Ovarian fibroma with ascites and hydrothorax (Meigs’ syndrome). JAMA. 1937;109:1684-1687.  [PubMed]  [DOI]  [Cited in This Article: ]
4.  Ryan RJ. PseudoMeigs syndrome. Associated with metastatic cancer of ovary. N Y State J Med. 1972;72:727-730.  [PubMed]  [DOI]  [Cited in This Article: ]
5.  Matsuzaki M, Murase M, Kamiya I, Horio S, Sakuma H. A case of Meigs’ syndrome resulting from rectal cancer (in Japanese with English abstract). J Jpn Soc Clin Surg. 1992;53:667-670.  [PubMed]  [DOI]  [Cited in This Article: ]
6.  Nagakura S, Shirai Y, Hatakeyama K. Pseudo-Meigs’ syndrome caused by secondary ovarian tumors from gastrointestinal cancer. A case report and review of the literature. Dig Surg. 2000;17:418-419.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 29]  [Cited by in F6Publishing: 33]  [Article Influence: 1.4]  [Reference Citation Analysis (0)]
7.  Ohsawa T, Ishida H, Nakada H, Inokuma S, Hashimoto D, Kuroda H, Itoyama S. Pseudo-Meigs’ syndrome caused by ovarian metastasis from colon cancer: report of a case. Surg Today. 2003;33:387-391.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 23]  [Cited by in F6Publishing: 27]  [Article Influence: 1.3]  [Reference Citation Analysis (0)]
8.  Feldman ED, Hughes MS, Stratton P, Schrump DS, Alexander HR. Pseudo-Meigs’ syndrome secondary to isolated colorectal metastasis to ovary: a case report and review of the literature. Gynecol Oncol. 2004;93:248-251.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 21]  [Cited by in F6Publishing: 26]  [Article Influence: 1.3]  [Reference Citation Analysis (0)]
9.  Rubinstein Y, Dashkovsky I, Cozacov C, Hadary A, Zidan J. Pseudo meigs’ syndrome secondary to colorectal adenocarcinoma metastasis to the ovaries. J Clin Oncol. 2009;27:1334-1336.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 8]  [Cited by in F6Publishing: 10]  [Article Influence: 0.7]  [Reference Citation Analysis (0)]
10.  Hosogi H, Nagayama S, Kanamoto N, Yoshizawa A, Suzuki T, Nakao K, Sakai Y. Biallelic APC inactivation was responsible for functional adrenocortical adenoma in familial adenomatous polyposis with novel germline mutation of the APC gene: report of a case. Jpn J Clin Oncol. 2009;39:837-846.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 17]  [Cited by in F6Publishing: 17]  [Article Influence: 1.1]  [Reference Citation Analysis (0)]
11.  Okuchi Y, Nagayama S, Mori Y, Kawamura J, Matsumoto S, Nishimura T, Yoshizawa A, Sakai Y. VEGF hypersecretion as a plausible mechanism for pseudo-meigs’ syndrome in advanced colorectal cancer. Jpn J Clin Oncol. 2010;40:476-481.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 16]  [Cited by in F6Publishing: 18]  [Article Influence: 1.3]  [Reference Citation Analysis (0)]
12.  Maeda H, Okabayashi T, Hanazaki K, Kobayashi M. Clinical experience of Pseudo-Meigs’ Syndrome due to colon cancer. World J Gastroenterol. 2011;17:3263-3266.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in F6Publishing: 4]  [Reference Citation Analysis (0)]
13.  Saito H, Koide N, Miyagawa S. Pseudo-Meigs syndrome caused by sigmoid colon cancer metastasis to the ovary. Am J Surg. 2012;203:e1-e3.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 8]  [Cited by in F6Publishing: 8]  [Article Influence: 0.6]  [Reference Citation Analysis (0)]
14.  Meigs JV. Fibroma of the ovary with ascites and hydrothorax; Meigs’ syndrome. Am J Obstet Gynecol. 1954;67:962-985.  [PubMed]  [DOI]  [Cited in This Article: ]
15.  Samanth KK, Black WC. Benign ovarian stromal tumors associated with free peritoneal fluid. Am J Obstet Gynecol. 1970;107:538-545.  [PubMed]  [DOI]  [Cited in This Article: ]
16.  Lin JY, Angel C, Sickel JZ. Meigs syndrome with elevated serum CA 125. Obstet Gynecol. 1992;80:563-566.  [PubMed]  [DOI]  [Cited in This Article: ]
17.  Abramov Y, Anteby SO, Fasouliotis SJ, Barak V. The role of inflammatory cytokines in Meigs’ syndrome. Obstet Gynecol. 2002;99:917-919.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 23]  [Cited by in F6Publishing: 31]  [Article Influence: 1.4]  [Reference Citation Analysis (0)]
18.  Abramov Y, Anteby SO, Fasouliotis SJ, Barak V. Markedly elevated levels of vascular endothelial growth factor, fibroblast growth factor, and interleukin 6 in Meigs syndrome. Am J Obstet Gynecol. 2001;184:354-355.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 38]  [Cited by in F6Publishing: 40]  [Article Influence: 1.7]  [Reference Citation Analysis (0)]
19.  Rizk B, Aboulghar M, Smitz J, Ron-El R. The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome. Hum Reprod Update. 1997;3:255-266.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 141]  [Cited by in F6Publishing: 147]  [Article Influence: 5.4]  [Reference Citation Analysis (0)]
20.  McClure N, Healy DL, Rogers PA, Sullivan J, Beaton L, Haning RV, Connolly DT, Robertson DM. Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome. Lancet. 1994;344:235-236.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 261]  [Cited by in F6Publishing: 272]  [Article Influence: 9.1]  [Reference Citation Analysis (0)]
21.  Lemming R. Meigs’ syndrome and pathogenesis of pleurisy and polyserositis. Acta Med Scand. 1960;168:197-204.  [PubMed]  [DOI]  [Cited in This Article: ]
22.  Terada S, Suzuki N, Uchide K, Akasofu K. Uterine leiomyoma associated with ascites and hydrothorax. Gynecol Obstet Invest. 1992;33:54-58.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 31]  [Cited by in F6Publishing: 32]  [Article Influence: 1.0]  [Reference Citation Analysis (0)]